IperionX Issues Shares in Cashless Settlement Deal

Iperionx Limited ( (AU:IPX) ) just unveiled an update.

IperionX Limited is a dual-listed company with ordinary shares traded on the ASX and ADSs on Nasdaq under the symbol IPX, providing investors access to its equity through both Australian and U.S. markets. The company’s share pricing reflects cross-border trading dynamics, with recent ASX and Nasdaq prices indicating active participation across exchanges.

The company is issuing 1,273,179 ordinary shares at $4.11 per share as part of a settlement agreement, replacing a cash payment obligation with equity. IperionX will not receive cash proceeds from this transaction, which slightly dilutes existing shareholders but allows the company to satisfy its settlement commitments without impacting its cash reserves.

The offering will settle around February 24, 2026, with the shares sold directly by the company rather than through underwriters or agents. This direct issuance structure simplifies the transaction and signals a targeted, negotiated resolution tied to the underlying settlement rather than a broad capital-raising effort.

The most recent analyst rating on (AU:IPX) stock is a Hold with a A$6.00 price target. To see the full list of analyst forecasts on Iperionx Limited stock, see the AU:IPX Stock Forecast page.

More about Iperionx Limited

IperionX Limited is listed on the Australian Securities Exchange, with American Depositary Shares trading on the Nasdaq Capital Market under the ticker IPX. The company issues ordinary shares with no par value, and its securities are positioned for investors in both Australian and U.S. equity markets.

Average Trading Volume: 1,126,331

Technical Sentiment Signal: Buy

Current Market Cap: A$1.97B

See more data about IPX stock on TipRanks’ Stock Analysis page.